Scientific Reports, 2023 This prospective, observer-masked, randomized clinical trial was conducted between December 2018 and June 2021 at Eye Hospital, China Academy of Chinese Medical Sciences. A total of 45 glaucoma patients from Beijing, China, were enrolled in this clinical
Yipeng Shi +8 more
doaj +2 more sources
Journal of Ophthalmology, 2021 Aim. Within the clinical setting, some patients have been identified as lacking in response to PGAs. This meta-analysis study aimed to evaluate the responsiveness of latanoprost, travoprost, bimatoprost, and tafluprost in OAG/OHT patients, latanoprost ...
Ziyan Cai +3 more
doaj +2 more sources
Developing a Chromatographic Method for Quantifying Latanoprost and Related Substances in Glaucoma Treatments [PDF]
PharmaceuticalsBackground/Objectives: Latanoprost is a leading active pharmaceutical ingredient belonging to the synthetic prostaglandin F2α analogs, widely used as a first-line treatment for open-angle glaucoma and increased intraocular pressure.
Katarzyna Asendrych-Wicik +2 more
doaj +2 more sources
Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma [PDF]
Clinics, 2020 OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost. The United States Food and Drug Administration approved latanoprostene bunod, a nitric oxide-donating prodrug of latanoprost, for ...
Yulong Wang, Yue Liao, Xin Nie
doaj +2 more sources
Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study [PDF]
Clinical OphthalmologyJason Bacharach,1 Ehsan Sadri,2 Gagan Sawhney,3 Casey Kopczynski,4 Mohinder M Merchea4 1North Bay Eye Associates, Inc, Petaluma, CA, USA; 2Visionary Eye Institute, Newport Beach, CA, USA; 3Georgia Eye Partners, Atlanta, GA, USA; 4Alcon, Inc, Fort Worth ...
Bacharach J +4 more
doaj +2 more sources
Efficacy and safety of prostaglandin drugs for elevated intraocular pressure: a Bayesian network meta-analysis [PDF]
Frontiers in MedicineObjectiveTo evaluate and compare the effectiveness and safety of latanoprost, bimatoprost, travoprost, and tafluprost in lowering intraocular pressure (IOP) in individuals with glaucoma or ocular hypertension.MethodsWe searched PubMed, Embase, Web of ...
Jieting Peng, Wenrui Huang, Junguo Duan
doaj +2 more sources
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial [PDF]
International Journal of Ophthalmology, 2021 AIM: To evaluate the therapeutic efficacy, safety and tolerability of newly developed preservative-free (PF) latanoprost generic [TJO-002] and compare it with benzalkonium chloride (BAK)-preserved latanoprost [Xalatan®] in patients with primary open ...
Joon Mo Kim +5 more
doaj +1 more source
Latanoprost eye drops induce conjunctival lymphatic vessel development [PDF]
International Journal of Ophthalmology, 2021 AIM: To investigate the effect of latanoprost eye drops on the conjunctival lymphatics. METHODS: Twenty-four healthy New Zealand White rabbits weighing 1.5 to 2.0 kg were randomly divided into three groups: latanoprost group (n=8) administered with ...
Kai Ma +3 more
doaj +1 more source
Cosmetics, 2023 Eyelashes, in addition to fulfilling eye-protective functions, generate an aesthetic impact. Latanoprost is a prostaglandin analog, commonly used for the treatment of glaucoma and intraocular hypertension.
Janette Ivone Espinoza-Silva +3 more
doaj +1 more source
Journal of Ophthalmology, 2022 Background: Prostaglandin analogs (e.g., latanoprost) are the first-line therapy for glaucoma. These medications, however, have a short antihypertensive effect due to low penetration of topical drug across the corneal epithelium, which causes the need ...
I. M. Mikheytseva +5 more
doaj +1 more source